1.Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants

作　　者：Mathias Lühr Hansen ;Adelina Pellicer ;Christian Gluud 等

出　　处：Trials. 2019 ;20(1):746-757.doi:10.1186/s13063-019-3756-y

出版社：BioMed Central

文章 ID：253248434

文章详细全文下载
2.Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

作　　者：Mathias Lühr Hansen ;Adelina Pellicer ;Christian Gluud 等

出　　处：Trials. 2019 ;20(1):811-821.doi:10.1186/s13063-019-3955-6

出版社：BioMed Central

文章 ID：253248486

文章详细全文下载
3.A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial

作　　者：Simon Hyttel-Sorensen ;Topun Austin ;Frank van Bel 等

出　　处：Trials. 2013 ;14(1):120.doi:10.1186/1745-6215-14-120

出版社：BioMed Central

文章 ID：95193505

文章详细全文下载
4.Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial

作　　者：Gerhard Pichler ;Sigrid Baumgartner ;Marlene Biermayr 等

出　　处：Trials. 2019 ;20(1):1-10.doi:10.1186/s13063-019-3258-y

出版社：BioMed Central

文章 ID：231355837

文章详细全文下载
5.The SURV1VE trial—sustained inflation and chest compression versus 3:1 chest compression-to-ventilation ratio during cardiopulmonary resuscitation of asphyxiated newborns: study protocol for a cluster randomized controlled trial

作　　者：Georg M. Schmölzer ;Gerhard Pichler ;Anne Lee Solevåg 等

出　　处：Trials. 2019 ;20(1):1-10.doi:10.1186/s13063-019-3240-8

出版社：BioMed Central

文章 ID：231355876

文章详细全文下载

	Gerhard Pichler	5篇
	Eugene Dempsey	4篇
	Adelina Pellicer	3篇
	Christian Gluud	3篇
	Cornelia Hagmann	3篇

	Gorm Greisen	3篇
	Gunnar Naulaers	3篇
	Monica Fumagalli	3篇
	Olivier Claris	3篇
	Anne Marie Heuchan	2篇
	Gabriel Dimitriou	2篇
	Georg M. Schmölzer	2篇
	Guoqiang Cheng	2篇
	Jakub Tkaczyk	2篇
	Janus Christian Jakobsen	2篇
	Jonathan Mintzer	2篇
	Karen B. Kreutzer	2篇
	Mathias Lühr Hansen	2篇
	Petra Lemmers	2篇
	Simon Hyttel-Sorensen	2篇
	Siv Fredly	2篇
	Tomasz Szczapa	2篇
	Topun Austin	2篇
	Alexander Avian	1篇
	Ana Vilan	1篇
	Anne Lee Solevåg	1篇
	Berit Grevstad	1篇
	Berndt Urlesberger	1篇
	Caroline Fray	1篇
	Claudia Roll	1篇
	Ebru Ergenekon	1篇
	Frank van Bel	1篇
	Gianluca Lista	1篇
	Hans Fuchs	1篇
	Hercilia Guimarães	1篇
	Jane Lindschou	1篇
	Laila Lorenz	1篇
	Lena Hellström-Westas	1篇
	Lilijana Kornhauser-Cerar	1篇
	Lukasz Karpinski	1篇

全文

出版年度

作者

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Gerhard Pichler")))) )) ) )"

	2019	4篇
	2013	1篇